MDR1 and CYP3A4 polymorphisms among African, Indian, and white populations in KwaZulu‐Natal, South Africa
暂无分享,去创建一个
H. Coovadia | M. Gordon | A. Mosam | S. Cassol | T. Palanee | P. Chelule | T. Page | Paul K. Chelule | Hoosen M. Coovadia
[1] Miyuki Kimura,et al. Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P‐glycoprotein , 2002, Clinical pharmacology and therapeutics.
[2] R. Kim,et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans , 2001, Clinical pharmacology and therapeutics.
[3] H. McLeod,et al. MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity. , 2001, Pharmacogenetics.
[4] S. Cavalli. Detection of Mbo II Polymorphism at the 5 * Promoter , 2001 .
[5] J. Witte,et al. CYP3A activity in African American and European American men: Population differences and functional effect of the CYP3A4*1B 5′‐promoter region polymorphism , 2000, Clinical pharmacology and therapeutics.